November 10th, 2008
Yesterday, Jeremy Barretto canvassed the SCC’s most recent decision (2008 SCC 61) concerning selection patents. Since Jeremy already surveyed the facts, procedural history, and analyses of the case, I will focus today on the issue of obviousness, noting some distinctions between the obviousness standard set out in the Apotex decision with the latest American decision [...]
November 10th, 2008
On Thursday November 6, 2008 the SCC released its decision in Apotex Inc. v. Sanofi-Synthelabo Canada Inc., 2008 SCC 61. This intellectual property case involves a dispute over selection patents between Apotex Inc. (“Apotex”), a generic drug manufacturer, and Sanofi-Synthelabo Canada Inc (“Sanofi”) who held the original patent. TheCourt published a summary of the Federal [...]
July 12th, 2007
On Thursday, July 5, 2007, the SCC granted the application for leave to appeal in the case of Apotex Inc. v. Sanofi-Synthelabo Canada Inc. et al., an appeal from the Federal Court of Appeal. This intellectual property law case deals with the requirements for patent protection. On April 28, 2003, Sanofi-Synthelabo Canada Inc. and Sanofi-Synthelabo [...]
 © Osgoode Hall Law School — This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 2.5 Canada License although certain works referenced herein may be separately licensed. |
 |
— This website is not authorized by the Supreme Court of Canada —
